Literature DB >> 7504367

A truncated form of herpes simplex virus type 1 immediate-early protein Vmw110 is expressed in a cell type dependent manner.

R D Everett1, A Cross, A Orr.   

Abstract

Herpes simplex virus type 1 (HSV-1) encodes five immediate-early (IE) genes, at least three of which are involved in the regulation of gene expression. Gene IE-1 is one of the few HSV-1 genes whose pre-mRNAs are spliced; the IE-1 pre-mRNA contains two introns, the second of which contains an in-frame stop codon which would terminate IE-1 translation if the intron were not excised. Previous work has shown that plasmids which have been constructed so as to express only the first two exons of Vmw110 can inhibit gene expression in transfection assays, whereas the normal intact protein is an activator of gene expression. In this paper we show that this predicted truncated Vmw110 protein is expressed during normal HSV-1 infection, and that it must be translated from IE-1 pre-mRNAs which retain the in-frame stop codon in the second intron. This truncated product is produced in amounts which depend upon the cell type infected. The possible consequences of these observations are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504367     DOI: 10.1006/viro.1993.1651

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  70 in total

1.  Herpes simplex virus ICP27 induces cytoplasmic accumulation of unspliced polyadenylated alpha-globin pre-mRNA in infected HeLa cells.

Authors:  P Cheung; K S Ellison; R Verity; J R Smiley
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Specific destruction of kinetochore protein CENP-C and disruption of cell division by herpes simplex virus immediate-early protein Vmw110.

Authors:  R D Everett; W C Earnshaw; J Findlay; P Lomonte
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

3.  Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture.

Authors:  X p Chen; J Li; M Mata; J Goss; D Wolfe; J C Glorioso; D J Fink
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  ICP0 induces the accumulation of colocalizing conjugated ubiquitin.

Authors:  R D Everett
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

5.  Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins.

Authors:  J Parkinson; R D Everett
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 6.  Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1.

Authors:  Ryan Hagglund; Bernard Roizman
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

7.  Herpes simplex virus requires poly(ADP-ribose) polymerase activity for efficient replication and induces extracellular signal-related kinase-dependent phosphorylation and ICP0-dependent nuclear localization of tankyrase 1.

Authors:  Zhuan Li; Yohei Yamauchi; Maki Kamakura; Tsugiya Murayama; Fumi Goshima; Hiroshi Kimura; Yukihiro Nishiyama
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

8.  Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro.

Authors:  Chris Boutell; Seth Sadis; Roger D Everett
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

9.  Point mutations in the herpes simplex virus type 1 Vmw110 RING finger helix affect activation of gene expression, viral growth, and interaction with PML-containing nuclear structures.

Authors:  R Everett; P O'Hare; D O'Rourke; P Barlow; A Orr
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  An early regulatory function required in a cell type-dependent manner is expressed by the genomic but not the cDNA copy of the herpes simplex virus 1 gene encoding infected cell protein 0.

Authors:  Alice P W Poon; Saul J Silverstein; Bernard Roizman
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.